Hologic Medicare Expands Coverage for Hologic's Biotheranostics Breast Cancer Test The firm said that the expanded coverage provides more women with access to a test that helps determine whether extended endocrine therapy is appropriate. US Department of Defense Awards $178.5M Contract to Hologic for SARS-CoV-2 Assays, Multiplex Tests The DoD said that it has awarded a firm-fixed-price contract to Hologic for its Panther Fusion SARS-CoV-2 and Aptima SARS-CoV-2 assays, among other products. Hologic Banking on MDx Acquisitions to Elevate Long-Term Revenue Growth Premium The company has invested revenues from its pandemic testing business to buy assets that are growing faster than its base business. Hologic Q2 Revenues Climb 104 Percent on Continued COVID-19 Demand, Recovery of Base Businesses The firm said that its MDx revenues were $935.3 million, up 391 percent from Q2 2020, based on strong global demand for its two SARS-CoV-2 assays. Hologic to Acquire Finnish MDx Firm Mobidiag for Approximately $795M Hologic intends to invest in assay development for Mobidiag's Novodiag PCR platform, which provides high-level multiplexing to detect infectious disease organisms. Mar 8, 2021 With Diagenode Acquisition, Hologic Expects to Expand Panther Fusion Testing Menu Premium Mar 1, 2021 Hologic Acquires European MDx Firm Diagenode for Approximately $159M Jan 27, 2021 Hologic Fiscal Q1 Revenues Rise 89 Percent as Dx Testing Demand Surges Jan 20, 2021 Biotheranostics' Breast Cancer Index Included in Latest NCCN Guidelines Jan 12, 2021 Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition Premium Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Jan 8, 2021 Hologic Preliminary Fiscal Q1 Revenues Rise 89 Percent on Coronavirus Testing Jan 5, 2021 Hologic to Acquire Molecular Diagnostics Firm Biotheranostics for $230M Dec 17, 2020 FDA Grants EUAs for Coronavirus Tests From Hologic, Genetworx, PacificDx Nov 20, 2020 Hologic Receives Additional FDA Approval for Diagnostic Use of HIV-1 Viral Load Test Nov 4, 2020 Hologic Fiscal Q4 Revenues Rise 56 Percent on Demand for SARS-CoV-2 Tests Nov 2, 2020 Hologic Wins $119M Contract From US Government to Expand COVID-19 Test Capacity Oct 6, 2020 FDA Revises Hologic Emergency Use Authorization to Include Asymptomatic Testing of SARS-CoV-2 Sep 28, 2020 Hologic Completes $950M Senior Notes Offering Sep 28, 2020 FDA Reissues Emergency Use Authorization for Hologic SARS-CoV-2 Assay for Asymptomatic Testing Sep 15, 2020 Hologic Prices $950M Offering of Senior Notes Sep 14, 2020 Hologic Gets WHO Prequalification Approval for HIV Assay, Offers $950M in Senior Notes Sep 11, 2020 Hologic Raises Q4 Revenue Guidance Jul 30, 2020 Hologic Continues to Ramp MDx Manufacturing Capacity in COVID-19 Fight Premium Jul 29, 2020 Hologic Q3 Revenues Decline Nearly 4 Percent as MDx Revenues More Than Double Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.